BioGram ApS: Financial statements 2025
CVR: 40922598
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BioGram ApS (CVR 40922598) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 287,937 and a net result of DKK 222,179 compared with DKK 170,237 the year before. That is an increase of 38.4% compared with the year before. Equity in the 2025 report amounted to DKK 127,799. The solvency ratio was 28.8%.
- Gross Profit
- DKK 287,937
- Profit/Loss
- DKK 222,179
- Equity
- DKK 127,799
- Total Assets
- DKK 444,348
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 288 t. | 222 t. | 128 t. | - |
| 2024 | - | 208 t. | 170 t. | 603 t. | - |
| 2023 | - | 371 t. | 283 t. | 436 t. | - |
| 2022 | - | 52 t. | 103 t. | 256 t. | - |
| 2021 | - | 233 t. | 182 t. | 452 t. | - |
How creditworthy is BioGram ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BioGram ApS has published its annual report for 2024. Gross profit came to DKK 208,037, and the net result was DKK 170,237.
About BioGram ApS
BioGram ApS is a Danish company of the type Anpartsselskab based in Ølstykke, founded in 2019. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Per Gram. The company is owned by BioGram Holding ApS. In 2025, the company reported a gross profit of DKK 287,937 and a net result of DKK 222,179 compared with DKK 170,237 the year before. Equity in the 2025 report amounted to DKK 127,799.